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Mechanism Underlying Counterregulation
of Autoimmune Diabetes by IL-4
Regula Mueller, Linda M. Bradley, their b cells are destroyed, resulting in overt diabetes
when the mice reach 4±6 months of age. The develop-Troy Krahl, and Nora Sarvetnick*
Department of Immunology ment of autoimmune diabetes in NOD mice is T cell±
mediated and requires the participation of both theThe Scripps Research Institute
La Jolla, California 92037 CD41 and the CD81 subsets (Wicker et al., 1986). We
recently generated transgenic (tg) NOD mice whose
pancreatic b cells ectopically express the cytokine in-
terleukin-4 (IL-4) (NOD-IL-4 mice), in an attempt to pre-Summary
vent IDDM by selectively targeting T cells that home to
the islets of Langerhans (Mueller et al., 1996). Indeed,Diabetes in nonobese diabetic (NOD) mice is an auto-
NOD-IL-4 mice, which possess a conventional T cellimmune disease characterized by the destruction of
repertoire, were completely protected from insulitis andthe b cells in the pancreas. We have previously re-
diabetes and demonstrated functional tolerance amongported that transgenic expression of interleukin-4
islet cell±reactive T cells. Our purpose here was to char-(IL-4) counterregulates the disease process, com-
acterize the mechanism governing acquired peripheralpletely protecting NOD mice from insulitis and diabe-
tolerance in these mice. In addition, the effect of T celltes. Here we demonstrate the presence of autoreactiv-
diversity on the induction of tolerance was investigatedity but lack of pathogenicity of the IL-4±regulated
by breeding NOD-IL-4 mice with another tg mouse strainlymphocytes. The importance of T cell diversity for
(BDC2.5) in which the majority of the CD41 T cells ex-the protective effect of IL-4 is demonstrated through
press a tg T cell receptor (TCR) specific for a b cellbreeding with transgenic BDC2.5 mice, which have
antigen (Katz et al., 1993). Our results suggest that pan-an almost exclusively monoclonal T cell repertoire.
creatic IL-4 performs its regulatory function mainlyLimitation of T cell diversity abrogated the protection
through the priming and amplification of nonpathogenicby IL-4. We suggest that ªimmune deviationº in NOD-
T cell specificities and that this effect is diversity de-IL-4 mice is mediated by the pancreatic tissue itself,
pendent.which causes activation of distinct, nonpathogenic T
cell specificities.
Results
Introduction
Splenocytes from NOD-IL-4 Mice Proliferate
Clonal deletion of autoreactive T cells in the thymus in Response to b Cells In Vitro
during these cells' maturation is the major mechanism Since T cells from NOD-IL-4 mice are functionally toler-
for establishing self-tolerance in an organism (Kappler ant to islet antigens, as indicated by the finding that
et al., 1987). We know, however, that this mechanism syngeneic islets transplanted under the kidney capsule
is by no means fully efficient and that autoreactive T of such mice are protected from autoimmune-mediated
cells, particularly those specific for antigens expressed destruction (Mueller et al., 1996), we now sought to de-
only in peripheral tissues, are readily encountered even termine whether NOD-IL-4 mice harbored any b cell±
in healthy individuals (Fowell and Mason, 1993; Scott specific T cells. To this end, splenocytes from 8-week-
et al., 1994). Self-tolerance is thus maintained in part old NOD-IL-4 mice and their non-tg NOD littermates
through mechanisms that act outside the thymus and were stimulated in vitro with irradiated whole NOD islet
control these potentially autoreactive cells. Several cells. Stimulation with concanavalin A (ConA) was used
mechanisms have been proposed to account for periph- to measure their general proliferation potential. As dem-
eral tolerance: peripheral clonal deletion (Webb et al., onstrated in Figure 1, splenocytes from NOD-IL-4 mice
1990); anergy via functional inactivation without deletion proliferated equally well as splenocytes from non-tg
(Mueller et al., 1989); and suppression by regulatory T NOD littermates in response to NOD islet cells. Thus,
cells that prevent effector T cells from displaying their pancreatic IL-4 did not prevent the priming of islet cell±
autoreactive potential (Fowell and Mason, 1993). reactive T cells in NOD-IL-4 mice. In addition, the re-
Insulin-dependent diabetes mellitus (IDDM) inhumans sponse to ConA was similar in both groups of mice,
is an autoimmune disease that selectively destroys insu- indicating that in vitro T cell proliferation after exposure
lin-producing b cells in the pancreatic islets of Langer- to this polyclonal stimulator is normal in NOD-IL-4 mice.
hans. Greatly facilitating the study of this disorder are
animal models such as nonobese diabetic (NOD) mice, Splenocytes from NOD-IL-4 Mice Do Not Transfer
which spontaneously develop a syndrome very similar Disease into NOD-scid Mice
to human IDDM. In these mice, an inflammatory infiltrate To determine whether T cells from NOD-IL-4 mice con-
consisting of macrophages and dendritic cells, as well tained diabetogenic T cells that might become patho-
as T and B cells, is observed around the islets at about genic in the absence of pancreatic IL-4, splenocyte
3±5 weeks after birth. As the mice age, inflammatory transfer experiments into NOD-scid mice were carried
cells gradually invade their islets, and the majority of out. NOD-scid mice are homozygous for the recessive
scid mutation, lack functional T and B cells, and are
thus free from insulitis and diabetes (Prochazka et al.,*To whom correspondence should be addressed.
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Figure 1. T Cell Proliferative Responses of NOD-IL-4 Splenocytes
In vitro proliferation of splenocytes from NOD-IL-4 mice (open bars)
and their non-tg littermates (hatched bars) in response to stimulation
with irradiated whole islet cells from NOD mice and with ConA.
Proliferation was determined after 4 days of culture by incorporation
of [3H]thymidine.
1992). Autoimmune diabetes is readily transferred from
diabetic NOD females into NOD-scid recipients using
whole splenocyte preparations (Christianson et al.,
1993). For our experiments, NOD-scid recipient mice
were injected with splenocytes from newly diagnosed
diabetic NOD females and aged-matched female NOD-
IL-4 littermates. Within 3±4 weeks after thecell transfers,
blood glucose values of NOD-scid recipients showed
Figure 2. Cumulative Incidence of Diabetes in NOD-scid Mice Fol-
that splenocytes from diabetic NOD females had in- lowing IV Injection of Splenocytes
duced diabetes (Figure 2A). In contrast, recipients of Recipients with two consecutive blood glucose values greater than
splenocytes from NOD-IL-4 females remained normo- 250 mg/dl in weekly tests were considered diabetic. (A) Donor sple-
glycemic (,250 mg/dl) throughout the 10-week ob- nocytes were isolated from either NOD-IL-4 females (triangles) or
from their diabetic NOD female littermates (squares). (B) Donorservation period. Histological examination revealed that
splenocytes were isolated from diabetic NOD females and theirsplenocytes from diabetic NOD mice induced extensive
NOD-IL-4 female littermates and injected at a 1:2 ratio (triangles).insulitis and selective destruction of pancreatic b cells in
Results from diabetic NOD females (squares) from (A) are given for
recipient mice. However, islets of NOD-scid mice given comparison.
splenocytes from NOD-IL-4 mice were free from infiltrat-
ing cells except for an occasional islet with some periin-
activation in vitro with ConA (Wang et al., 1996), thussulitis (data not shown). Clearly, the splenocytes had
revealing these cells' pathogenic potential. Similarly,homed to the islets but could not induce destruction of
periinsulitis or insulitis was visible in the majorityof isletsb cells. Thus, islet cell±reactive T cells in NOD-IL-4 mice
in pancreata of NOD-scid mice within 3 weeks after theymaintained their state of functional tolerance even in
received ConA-activated splenocytes from 8-week-oldthe absence of pancreatic IL-4.
NOD mice (Figure 3). It is noteworthy that ConA-acti-
vated splenocytes from age-matched NOD-IL-4 lit-Splenocytes from NOD-IL-4 Mice Have No
termates induced significantly less periinsulitis (p ,Regulatory Effect on Splenocytes
0.05) and insulitis (p , 0.02). Presumably, splenocytesfrom Diabetic Mice
in NOD-IL-4 mice were not simply in a state of inactiva-The possibility that these nonpathogenic cells in NOD-
tion that could be overcome by artificial in vitro stimula-IL-4 mice were able to regulate diabetogenic T cells was
tion, but rather lacked the disease-causing potentialtested with cotransfer experiments. First, splenocytes
characteristic of splenocytes from NOD mice.from diabetic NOD females and age-matched NOD-IL-4
female littermates were mixed at a ratio of 1:2; then the
Pancreatic IL-4 Partially Prevents Diabetesmixture was injected into NOD-scid mice. As shown
after Cyclophosphamide Injectionin Figure 2B, recipients of the mixed cell preparation
Injections of cyclophosphamide (CY) accelerate pancre-developed diabetes at the same rate and penetrance
atic b cell destruction in both genders of NOD miceas recipients of splenocytes from diabetic NOD mice
(Harada and Makino, 1984). To determine whether pan-alone. This failure to inhibit the transfer of disease by
creatic IL-4 could also prevent this accelerated form ofdiabetogenic T cells denotes the absence of regulatory
the disease, 8- to 12-week-old male NOD-IL-4 mice andT cells in the spleen of NOD-IL-4 mice.
their non-tg male NOD littermates were injected with
200 mg/kg CY intraperitoneally. As seen in Figure 4,Insulitic Potential of Splenocytes
67% of NOD males became diabetic within 2±4 weeksfrom NOD-IL-4 Mice Is Low
after the first CY injection. In contrast, only 31% of NOD-Splenocytes from prediabetic NOD mice can induce pre-
mature insulitis in neonatal NOD recipients following IL-4 males injected with CY developed hyperglycemia,
Counterregulation of Autoimmune Diabetes by IL-4
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Figure 3. Insulitic Potential of Splenocytes after In Vitro Activation
with ConA
Splenocytes were isolated from 8-week-old NOD-IL-4 mice and their
Figure 4. Cumulative Incidence of Diabetes after CY Injections intonon-tg littermates and stimulated in vitro with ConA for 48 hr. Cells
NOD-IL-4 Males and Their Male Non-tg Littermateswere subsequently injected IV into NOD-scid mice. Three weeks
later, islets of recipients were scored for the presence of insulitis Open squares, NOD-IL-4 males; filled squares, male non-tg litter-
(filled bars), periinsulitis (hatched bars), or absence of inflammation mates. Mice were treated with CY on days 0 and 14, and blood
(open bars). glucose values were determined weekly. Mice with two consecu-
tive blood glucose values greater than 250 mg/dl were considered
diabetic.
some of them as late as 7 weeks after the first CY injec-
tion (p , 0.05). Histological examination revealed that 14% among males, which is similar to that in our regular
islets in pancreata of CY-injectedNOD mice wereheavily NOD/Shi colony. As before (Mueller et al., 1996), none
infiltrated with inflammatory cells. Some inflammatory of the single tg IL-41 mice developed diabetes.
cells were also present in pancreata of CY-injected Upon histological examination, pancreata from non-
NOD-IL-4 mice, albeit to a lesser extent and mostly tg mice had the characteristic pathology of NOD mice.
surrounding the islets (data not shown). Thus, the non- As described previously, islets in pancreata of single tg
pathogenic state of splenocytes from NOD-IL-4 mice IL-41 mice were only occasionally surrounded by inflam-
could be partially reversed into a pathogenic one with CY. matory cells (Mueller et al., 1996). Far more involved in
disease were pancreata of BDC2.51 single and IL-41/
BDC2.51 double tg mice in which inflammatory infiltratesIL-4 Regulation Is Repertoire Dependent
To determine whether the regulatory effect of pancreatic were extensive, sometimes even reminiscent of lympho-
mas (Figure 7). Despite the extensive pancreatic inflam-IL-4 depended on the presence of a diverse T cell reper-
toire, NOD-IL-4 mice were crossed with BCD2.5 mice mation in BDC2.51 single tg mice, b cells staining
strongly for insulin, glucagon, and somatostatin were(Katz et al., 1993). BDC2.5 mice are tg NOD mice bearing
rearranged genes for the TCR-a (Va1) and TCR-b (Vb4) easily identified. In IL-41/BDC2.51 double tg mice, how-
ever, only an occasional insulin-positive cell was detect-chains from a diabetogenic CD41 T cell clone isolated
from a diabetic NOD mouse (Haskins et al., 1988). The able, although glucagon and somatostatin staining re-
sembled that for BDC2.51 single tg mice. Both groupspresence of this transgene dramatically enriched the
population of islet cell±specific CD41 T cells in the of mice had infiltrating cells consisting mostly of CD41
and CD81 T cells as early as 4 weeks of age. Stainingperiphery, as demonstrated by the expression of Vb4
(Figure 5). Accordingly, the CD4/CD8 ratio increased with an antibody (Ab) to the IL-2 receptor revealed large
numbers of CD251 cells in inflamed pancreata of IL-41/markedly in BDC2.5 mice compared to their non-tg lit-
termates. Furthermore, approximately 93% of CD41 and BDC2.51 double tg mice, indicating that many of these
cells had just recently been activated. In contrast, few71% of CD81 T cells in BDC2.5 mice displayed Vb4.
These cells did not display significant differences in the CD251 cells appeared in pancreatic lesions of BDC2.51
single tg mice (Figure 7). We conclude that islet-reactivesurface expression of L-selectin, CD45RB, and CD44
compared to CD4 cells from NOD mice. However, the CD41 T cells with known diabetogenic potential can be
activated in the presence of pancreatic IL-4, and cancells were found to be entirely of resting phenotype, as
judged by the lack of IL-2 receptor (CD25) expression promote disease.
To determine the diabetogenic potential of spleno-and low forward scatter (data not shown).
The effect of pancreatic IL-4 on the development of cytes from single and double tg BDC2.5 mice, transfers
into NOD-scid mice were performed. Splenocytes iso-diabetes in BDC2.5 mice was assessed in non-tg, IL-41
single tg, BDC2.51 single tg, and IL-41/BDC2.51 double lated from BDC2.5 mice and subsequently injected into
NOD-scid recipients did not induce diabetes during thetg offspring from NOD-IL-4 3 BDC2.5 breedings (Figure
6). During the 6-month observation period, none of the 10-week observation period (Figure 8). Histological ex-
amination of pancreata of recipient mice indicated theBDC2.51 single tg males or females became diabetic.
However, in the double tg IL-41/BDC2.51 mice, diabetes presence of periinsulitis. However, after polyclonal acti-
vation in vitro with ConA, these cells induced diabetesfirst became overt in both genders as early as 4±5 weeks
of age, the cumulative incidence reaching 75% in males within 7±10 days after transfer into NOD-scid recipients,
consistent with the observation that they were in a rest-and 82% in females by 6 months of age. In non-tg mice,
the incidence of diabetes was 70% among females and ing state in vivo, which readily changed to a pathogenic
Immunity
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Figure 5. Cell Surface Expression of Differentiation and Activation Markers on BDC2.5 T Cells
Spleen cells from BDC2.5 mice (left), aged 8 weeks, or NOD mice (right), aged 10 weeks, were stained for the indicated markers.
(A) Percentages of CD41 T cells (y axis) and CD81 T cells (x axis).
(B) Expression of Vb4 by CD41 T cells (top) and CD81 T cells (bottom).
(C) Markers that are affected by priming. Values for L-selectin and CD25 are determined by comparison to the isotype controls shown. Values
for CD44 and CD45RB are for high-expressing cells. Left, Vb41 T cells from BDC2.5 mice; right, CD41 T cells from NOD mice.
state through artificial activation in vitro. Splenocytes detectable in animals at about 4 weeks of age and re-
mains for life (Kaufman et al., 1993; Tisch et al., 1993).isolated from IL-41/BDC2.51 double tg mice and subse-
quently injected into NOD-scid recipients transferred Initially, the response is limited to a specific region of
glutamic acid decarboxylase but later spreads intra-disease into 50% of the recipient NOD-scid mice by 3
weeks after the transfer. and intermolecularly to other determinants, eventually
involving T cells of many specificities. Thus, one way to
prevent the disease is to intercept the generation ofDiscussion
these specificities. An example of such regulatory inter-
vention is the expression of TNFa in pancreatic b cellsAutoimmune diabetes in NOD mice develops through
of tg NOD mice, protecting them from diabetes (Grewalstages that extend from the neonatal period until clinical
et al., 1996). However, we found here that such a mecha-onset at 4±6 months of age. We previously have reported
nism of protection was not attributable to the absencethat the expression of IL-4 in pancreatic b cells in tg
of sensitized autoreactive T cells in NOD-IL-4 mice. InNOD mice profoundly interferes with this disease cas-
fact, splenocytes from NOD-IL-4 mice proliferated incade, thus completely abolishing the development of
response to whole b cells as effectively as did spleno-insulitis and diabetes (Mueller et al., 1996). In the current
cytes from non-tg littermates, indicating that pancreaticstudy, the mechanisms underlying this immunoprotec-
IL-4 did not prevent the priming of autoimmune T cellstion were explored by determining the regulatory effects
with islet antigens. Also, local IL-4 expression did notexterted by pancreatic IL-4 in the NOD-IL-4 pancreas
lead to a generalized state of nonresponsiveness, sinceand by establishing the requirements for this regulation.
polyclonal stimulation with ConA induced comparableThe results of this study indicate that (1) T cell prolifera-
proliferative responses in NOD and NOD-IL-4 mice.tion in vitro of splenocytes from NOD-IL-4 mice is nor-
The demonstration of autoreactive T cells in the ab-mal; (2) islet cell±reactive T cells in NOD-IL-4 mice re-
sence of disease in NOD-IL-4 mice raised the questionmain functionally tolerant in the absence of pancreatic
as to whether the pathogenic specificities could be re-IL-4 and after artificial in vitro activation with ConA; (3)
vealed in the absence of pancreatic IL-4. In our transferregulation is partially lost after in vivo stimulation with
experiments, this was not the case, since splenocytesCY; (4) NOD-IL-4 mice lack regulatory T cells that can
from NOD-IL-4 mice failed to induce insulitis or diabetescontrol diabetogenic T cells; and (5) such regulation by
in any of the NOD-scid recipients. Regulation by IL-4IL-4 is dependent on T cell diversity.
evidently proceeded through expansion of a nonpatho-Diabetes in the NOD mouse is T cell dependent, as
genic repertoire among autoreactive T cells and per-indicated by Ab treatment (Miller et al., 1988; Shizuru et
sisted in the absence of pancreatic IL-4.al., 1988; Hayward and Schreiber, 1989) and cell transfer
Factors determining whether diabetes develops areexperiments (Wicker et al., 1986; Christianson et al.,
1993). T cell reactivity against b cell antigens is first thought to include not only the extent of expansion of
Counterregulation of Autoimmune Diabetes by IL-4
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expression in pancreatic lesions by favoring T helper 1
(Th1) activity and shifting the cytokine balance from Th2
to Th1 predominance (Rothe et al., 1994). However, the
reduction in disease incidence compared with NOD
mice after injection of CY into NOD-IL-4 mice demon-
strated that the nonpathogenic state of splenocytes in
NOD-IL-4 mice was not completely perturbable, not
even by an overwhelming Th1 response.
Taken together, the foregoing results indicate that
autoreactive T cells are indeed generated in NOD-IL-4
mice, albeit with permanent alteration toward a nonde-
structive phenotype. This state of unresponsiveness,
once established, is highly stable and independent of
pancreatic IL-4. Furthermore, the regulatory agent is the
pancreatic tissue, not the lymphocytes.
Diabetes in NOD mice is a complex disease, involving
autoreactive T cells of many distinct specificities (Tisch
and McDevitt, 1996). BDC2.5 tg mice are NOD mice that
contain a T cell repertoire of essentially one specificity,
since they overexpress a TCR that recognizes a natural,
yet unidentified autoantigen in the NOD mouse. In addi-
tion, after backcrossing onto the NOD background, the
original N3 mice, housed under conventional conditions,
had a significantly earlier onset of disease and higher
disease incidence than their non-tg NOD littermates
(Katz et al.,1993). In contrast toexpectations, nodisease
arose in the BDC2.5 tg mice, which were housed under
specific pathogen±free (SPF) conditions in our colony.
An explanation for the differing observations in our col-
ony versus that of the first published report (Katz et al.,
1993) is not available. However, another report from theFigure 6. Cumulative Incidence of Diabetes among Female and
same group (Kurrer et al., 1997) is consistent with ourMale Offspring from NOD-IL-4 3 BDC2.5 Breedings
present resultsÐthat is, a greatly reduced incidence of(A) Female offspring; (B) male offspring. Blood glucose values were
diabetes in BDC2.5 mice once they were housed underdetermined twice a month in non-tg (squares), IL-41 single tg (cir-
cles), BDC2.51 single tg (triangles), and IL-41/BDC2.51 double tg SPF and not under conventional conditions. We have
(diamonds) mice. Mice were considered diabetic if two consecutive demonstrated that most T cells from BDC2.5 mice in
blood glucose values greater than 250 mg/dl were observed. our colony expressed the TCR transgene according to
Vb4 expression. We also can infer that the transgene
autoreactive T cells but also active regulation that pre- retained its pancreatic islet antigen specificity, based
vents progression from insulitis to diabetes. Indeed, T on the extensive, monoclonal appearing insulitis and
cell clones with immunosuppressive properties have periinsulitis apparent in all the BDC2.5 tg mice, despite
been identified in NOD mice (Pankewycz et al., 1991; the absence of clinical diabetes. Furthermore, Vb4-
Pankewycz et al., 1992) and also in Bio-Breeding rats, expressing T cells were resting and splenocytes from
another animal model of IDDM (Fowell and Mason, BDC2.5 mice rapidly transferred disease into NOD-scid
1993). In our experiments, T cells in NOD-IL-4 mice did recipients after artificial activation in vitro with ConA.
not possess any apparent regulatory activityon cotrans- Therefore, the differing outcomes among BDC2.5 mice
fer with splenocytes from diabetic NOD mice into NOD- may stem from living conditions of the original, conven-
scid recipients. Clearly, splenocytes from NOD-IL-4 tional colony, where pathogens might have kept the tg T
mice did not protect against the effects of diabetogenic cells in a perpetual state of activation, leading to clinical
T cells previously primed in vivo. In contrast, our previ- disease. This view is consistent with the study of Gover-
ous work (transfer of splenocytes from diabetic NOD man et al. (1993), who found that their tg mice that
mice into irradiated NOD-IL-4 mice) showed that pan- express a myelin basic protein±specific TCR developed
creatic IL-4 can counterregulate the destructive action spontaneous experimental allergic encephalomyelitis
of diabetogenic cells (Mueller et al., 1996). Conse- when kept under normal conditions but not when kept
quently, the regulation seen in NOD-IL-4 mice originated in an SPF facility.
from the IL-4±producing tissue and was not mediated Overall, the results obtained with IL-41/BDC2.51 dou-
by the nonpathogenic leukocytes residing in the spleen. ble tg mice suggest that T cell diversity and expansion
The counterregulation by IL-4 was only partially dis- of nonpathogenic specificities are required for counter-
turbed after the injection of CY. Indeed, CY induced regulation of diabetes induced by IL-4. In the absence
disease in 31% of the tg mice. CY is widely used to of a diverse T cell response, pancreatic IL-4 failed to
accelerate and synchronize the disease's development protect the islets or to induce tolerance. In fact, the
in NOD mice, although the mechanism remains enig- consequent diabetes in IL-41/BDC2.51 double tg mice
arose from proinflammatory mechanisms inherent tomatic. CY injections can profoundly up-regulate IFNg
Immunity
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Figure 7. Histological Analysis of Pancreata from BDC2.51 Single Tg and IL-41/BDC2.51 Double Tg Mice
(A) Pancreas from a BDC2.51 tg mouse, hematoxylin and eosin (H1E) stained. Note the extensive inflammatory infiltrate in the pancreas.
(B) Pancreas from a BDC2.51 tg mouse, higher magnification, H1E stained. Note the substantial remaining islet cell mass.
(C) Pancreas from a BDC2.51 tg mouse, immunostained for insulin using DAB as a chromagen. Note the substantial islet cells mass stained
positively for insulin (brown-red color).
(D) Pancreas from an IL-41/BDC2.51 double tg mouse, H1E stained. Note the extensive infiltrate.
(E) Pancreas from an IL-41/BDC2.51 double tg mouse, higher magnification, H1E stained. Note extensive infiltrate and the absence of
discernible islet structures.
(F) Pancreas from an IL-41/BDC2.51 double tg mouse, immunostained for insulin using DAB as a chromagen. Note the lack of islet structures
and paucity of insulin-producing cells.
(G) Pancreas from a BDC2.51 tg mouse stained with anti-CD4. Note the extensive infiltration of CD41 T cells.
(H) Pancreas from a BDC2.51 tg mouse stained with anti-CD8. Note the extensive infiltration of CD81 T cells.
(I) Pancreas from a BDC2.51 tg mouse stained with anti-IL-2 receptor. Note the lack of activation of infiltrating cells.
(J) Pancreas from an IL-41/BDC2.51 double tg mouse stained with anti-CD4. Note the extensive infiltration of CD41 T cells.
(K) Pancreas from an IL-41/BDC2.51 double tg mouse stained with anti-CD8. Note the extensive infiltration of CD81 T cells.
(L) Pancreas from an IL-41/BDC2.51 double tg mouse stained with anti-IL-2 receptor. Note the high proportion of activated infiltrating cells.
many cytokines, relieving the b cell±specific BDC2.5 T cells encountered within. Following exposure to this cy-
tokine in the tissue, diabetogenic T cells can no longercells from their eternal state of rest. Our present and past
results demonstrate that IL-4 expression in pancreatic mediate disease, although their autoreactivity to b cells
is easily demonstrated in vitro.tissue is required for counterregulation of diabetogenic
T cells. Although lymphocytes from NOD-IL-4 mice can- Within the tissue, antigen-presenting cells (APCs) me-
diate the activation of islet antigen±specific T cells andnot themselves mediate disease, they lack the ability to
positively regulate diabetogenic lymphocytes, which the the development of effectors. Cytokine-mediated coun-
terregulation that occurs through these tissue-localizedIL-4±producing tissue can do. Therefore the mechanism
of protection must originate in the IL-4±producing pan- APCs might promote the developmentof nonpathogenic
T cell specificities. Potent effects of Th2 cytokines oncreatic tissue, which can influence the reactivity of T
Counterregulation of Autoimmune Diabetes by IL-4
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Blood Glucose Measurements
Glucose levels were measured in blood withdrawn from the retroor-
bital sinuses of anesthetized mice using Glucometer Elite blood
glucose test strips (Bayer, Elkhart, IN). Mice with two consecutive
blood glucose values greater than 250 mg/dl were considered dia-
betic.
Antigen Preparation
Antigen for proliferation assays was in the form of whole NOD islet
cells, as described previously (Katz et al., 1993). In brief, islets were
first purified from pancreata of 4- to 5-week old NOD mice by colla-
genase digestion and hand-picking under the microscope and then
treated with trypsin-EDTA (GIBCO, Grand Island, NY) for 8 min at
378C to obtain a single-cell suspension. Debris were removed by
centrifugation of the cells through a cushion consisting of 4% bovine
serum albumin in minimal essential medium. Single islet cells were
Figure 8. Cumulative Incidence of Diabetes after Splenocyte Trans- irradiated with 3500 rad before use in the proliferation assay.
fer into NOD-scid Mice
Proliferation AssaySplenocytes were isolated from BDC2.51 single tg mice and immedi-
Splenocyte suspensions were prepared in HL-1 serum-free mediumately transferred (circles) or first stimulated in vitro with ConA for
(Hycor, Irvine, CA) from 8-week-old NOD-IL-4 females and their non-48 hr and then transferred (squares). Splenocytes were also isolated
tg female littermates according to standard procedures. Assaysfrom IL-41/BDC2.51 double tg mice and immediately transferred
were performed in 96-well plates in triplicate by culturing 4 3 105(diamonds). Blood glucose values in recipients were determined
responder splenocytes with 2 3 104 irradiated islet cells in a totalonce a week. Mice were considered diabetic if two consecutive
volume of 200 ml for 96 hr. [3H]thymidine was added during the lastblood glucose values greater than 250 mg/dl were observed.
18 hr of culture. ConA was used at a concentration of 1 mg/ml.
Splenocyte Transfer into NOD-scid Mice
APCs are well established. Since initial priming of islet- Newly diagnosed diabetic NOD females and age-matched NOD-
specific T cells with antigen does occur in the IL-4 tg IL-4 female littermates were used as splenocyte donors. For the
NOD mouse, subsequent restimulation in tissues may individual transfers, 2 3 107 cells from either NOD or NOD-IL-4
mice were injected intravenously (IV) into 8±12 week-old NOD-scidbe defective. It is noteworthy that IL-4 causes reduced
females. For the cotransfer experiments, 2 3 107 cells from diabeticexpression of FcgRI on macrophages (Fanger et al.,
NOD females were injected IV together with 4 3 107 cells from NOD-1997), limiting their ability to take up and present tissue
IL-4 females. Blood glucose values of recipients were measured
antigens to T cells. Macrophage infiltration is required weekly following the cell transfer.
for diabetes to occur in the NOD mouse (Hutchings et
al., 1990), and these cells may act to restimulate primary ConA Activation of Splenocytes In Vitro and Transfer
into NOD-scid Miceautoreactive T cells whose activation is initiated by den-
Splenocytes were isolated from 10- to 12-week-old mice and resus-dritic cells. Thus, IL-4 exposure could eliminate the am-
pended at 4 3 106 cells/ml in complete RPMI 1640 (10% fetal calfplification of autoreactive responses and the generation
serum, 1 mM Na pyruvate, 2 mM L-glutamine, 50 mm 2-mercaptoeth-
of islet antigen±specific memory effectors through low- anol, 100 U/ml penicillin, and 100 mg/ml streptomycin) supple-
ered expression of FcgRI on macrophages. Such a mented with 5 mg/ml ConA. After 48 hr at 378C, cells were washed,
mechanism would be easily overwhelmed by mono- and residual ConA was neutralized with 10 mg/ml methyl-2-D-man-
nopyranoside (Sigma, St. Louis, MO). After two additional washes,clonality of pathogenic T cells, but capable of quieting
cells were resuspended at 2 3 108 cells/ml in phosphate-bufferedthe diverse T cell population within the diabetogenic
saline, and 2 3 107 cells were injected IV into NOD-scid mice. BloodNOD spleen, which may require restimulation within the
glucose values of recipients were measured weekly after the cell
target tissue. transfer.
Experimental Procedures CY Treatment
CY (Sigma, St. Louis, MO) was dissolved in 0.9% NaCl at 20 mg/ml
Mice immediately before injection. NOD-IL-4 males aged 10±12 weeks
The construction of tg NOD-IL-4 mice, which express IL-4 in their and their non-tg male littermates were injected with 200 mg/kg
pancreatic b cells under the control of the human insulin promoter, intraperitoneally on days 0 and 14. All mice were nondiabetic before
has been described (Mueller et al., 1996). The tg BDC2.5 mice (Katz treatment. Blood glucose values were measured weekly after the
et al., 1993) backcrossed onto the NOD background for 12 genera- first injection. Because CY treatment of NOD mice yields variable
tions were a generousgift from Diane Mathis and Christophe Benoist results in terms of disease incidence, typically only 50%±80% of
(Illkirch, France). NOD-IL-4 mice and BDC2.5 mice were propagated recipients are affected (Parish et al., 1993).
by breeding with NOD/Shi mice obtained from the Scripps rodent
breeding colony. All mice were housed together under SPF condi- Histology
tions. Littermates were used in all studies. Breeding pairs of NOD/ Mice were sacrificed, and pancreata were excised and then halved.
Lt-scid/scid mice were obtained from The Jackson Laboratories One half was fixed in 10% normal buffered formalin and embedded
(Bar Harbor, ME) and bred at Scripps. NOD-scid mice were handled in paraffin; the other half was embedded in optimal cutting tempera-
under sterile conditions in a laminar flow hood and housed in sterile ture medium and snap frozen in liquidnitrogen. Tissue sections were
micro-isolator cages. conventionally stained with hematoxylin and eosin for histological
evaluation or prepared for immunocytochemical techniques as de-
scribed (Mueller et al., 1997). Primary Abs used on paraffin sectionsTyping of Mice
The transgene's presence in NOD-IL-4 mice was verified by poly- were guinea pig anti-porcine insulin, rabbit anti-porcine glucagon,
and rabbit anti-human somatostatin (all from DAKO, Carpenteria,merase chain reaction typing of tail DNA.BDC2.5 mice weretyped by
determining Vb4 expression on CD31 T cells purified from peripheral CA). On cryosections, Abs to murine L3T4, Ly2, and B 220 (all from
Pharmingen, San Diego, CA) were usedto demonstrate the presenceblood.
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of CD41 and CD81 T cells and B lymphocytes, respectively. The blockade of adhesion-promoting receptor on macrophages. Nature
348, 639±642.Mac-1 Ab (Boehringer Mannheim, Indianapolis, IN) was used to
identify macrophages, and the rat anti-CD25 Ab (Pharmingen) to Kappler, J.W., Roehm, M., and Marrack, P. (1987). T cell tolerance
identify activated T cells. by clonal elimination in the thymus. Cell 49, 273±280.
Islets on hematoxylin and eosin±stained sections from pancreata Katz, J.D., Wang, B., Haskins, K., Benoist, C., and Mathis, D. (1993).
of NOD-scid mice were further scored for absence of inflammation, Following a diabetogenic T cell from genesis through pathogenesis.
and presence of periinsulitis (infiltrate around the islet) and insulitis Cell 74, 1089±1100.
(infiltration of the islet).
Kaufman, D.L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting,
G.S.P., Robinson, P., Atkinson, M.A., Sercarz, E.E., Tobin, A.J., and
Flow Cytometric Analysis: Lehmann, P.V. (1993). Spontaneous loss of T-cell tolerance to glu-
Peripheral blood was obtained through puncture of the retroorbital tamic acid decarboxylase in murine insulin-dependent diabetes. Na-
plexus of anesthetized mice. Cells were stained by incubation for 15 ture 366, 69±72.
min at 48C with anti-CD3-phycoerythrin (PE), anti-CD4±fluorescein
Kurrer, M.O., Pakala, S.V., Hanson, H.L., and Katz, J.D. (1997). b
isothiocyanate (FITC), anti-CD4-PE, anti-CD8-PE, anti-Vb4-FITC,
cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl.
anti-L-selectin-FITC, anti-CD44-FITC, anti-CD45RB-TRITC, and Acad. Sci. USA 94, 213±218.
anti-CD25-FITC (all Abs from Pharmingen). Red blood cells were
Miller, B.J., Appel, M.C., O'Neil, J.J., and Wicker, L.S. (1988). Bothsubsequently lysed with lysis buffer (Sigma). Leukocytes were fixed
the Lyt-21 and L3T41 T cell subsets are required for the transfer ofin 1% formaldehyde and analyzed with a Becton Dickinson FACS.
diabetes in nonobese diabetic mice. J. Immunol. 140, 52±58.A minimum of 10,000 cells was analyzed for each sample.
Mueller, D.L., Jenkins, M.K., and Schwartz, R.H. (1989). Clonal
expansion versus functional clonal inactivation: a costimulatory sig-Statistical Analysis
nalling pathway determines the outcome of T cell antigen receptorStatistical analyses were performed using analysis of variance and
occupancy. Annu. Rev. Immunol. 7, 445±480.chi-square tests as appropriate.
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